A critical assessment of generic substitution for the obstetrician-gynecologist

International Journal of Fertility and Women's Medicine

Volumn 46, Issue 6, 2001, Pages 286-295

  Keith, Louis G ^a   Oleszczuk, Jaroslaw J ^a   Ahranjani, Matthew ^a  

^a Prentice Women's Hospital   (United States)

Author keywords

Bioavailability; Critical dosage; Medical economies; Narrow therapeutic index; Oral contraceptives; Ovulation induction; Therapeutic equivalence

Indexed keywords

GENERIC DRUG; ORAL CONTRACEPTIVE AGENT;

ARTIFICIAL INSEMINATION; BIOEQUIVALENCE; COST CONTROL; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; GYNECOLOGY; HEALTH ECONOMICS; OBSTETRICS; OVULATION INDUCTION; PHARMACOKINETICS; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL AVAILABILITY; CONTRACEPTIVE AGENTS, FEMALE; DRUG COSTS; DRUGS, GENERIC; FEMALE; GYNECOLOGY; HUMANS; OBSTETRICS; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 0035497876     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Hudson J: Generic take-up in the pharmaceutical market following patent expiry. A multi-country study. Int Rev Law Econ 20:205-221, 2000.
2. A special report: An assessment of generic substitution for critical dose drugs. Hosp Pract 1999 (Nov).
3. Dighe SV: A review of the safety of generic drugs. Transplant Proc 31:23S-24S, 1999.
4. Meyer GF: History and regulatory issues of generic drugs. Transpl Proc 31:10S-12S, 1999.
5. Keith LG, Oleszczuk JJ, Stika CS, et al: Generics: What's in a name? Int J Fertil 43:139-149, 1998.
6. Rheinstein PH: The generic drug approval process. Am Fam Phys 48:1357-1360, 1993.
7. Colaizzi JL, Lowenthal DT: Critical therapeutic categories: A contraindication to generic substitution? Clin Ther 8:370-379, 1986.
8. Ansbacher R: Interchangeability of low-dose oral contraceptives. Are current bioequivalent testing measures adequate to ensure therapeutic equivalency? Contraception 43:139-147, 1991.
9. Ansbacher R: Low-dose oral contraceptives: Health consequences of discontinuation. Contraception 62:285-288, 2000.
10. Endrenyi L, Schulz M: Individual variation and the acceptance of average bioequivalence. Drug Inf J 27:195-201, 1993.
11. Rosenberg MJ, Waugh MS: Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179:577-582, 1998.
12. Rosenberg MJ, Waugh MS: Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 180:S276-S279, 1999.
13. Jackson M, Berger GS, Keith LG (eds): Vaginal Contraceptives. G.K. Hall, Boston, 1981.
14. Durant RH, Jay MS, Linder CW, et al: Influence of psychosocial factors on adolescent compliance with oral contraceptives. J Adolesc Health Care 5:1-6, 1984.
15. Rosenberg MJ, Waugh MS: Improving oral contraceptive use: Factors associated with poor compliance. Proceedings of American College of Obstetricians and Gynecologists Annual Clinical Meeting, Denver, Colorado, April 1995.
16. Grimes DA, Raymond EG, Scott Jones B: Emergency contraception over-the-counter: The medical and legal imperatives. Obstet Gynecol 98:151-155, 2001.
17. Rosenberg MJ, Waugh MS, Burnhill MS: Compliance, counseling and satisfaction with oral contraceptives: A prospective evaluation. Fam Plan Perspect 30:89-92 & 104, 1998.
18. Rosenberg MJ, Meyers AN: Improving oral contraceptive compliance. Fem Patient 23:83-87 & 90, 1998.
19. Keith LG, Oleszczuk JJ: Iatrogenic multiple birth, multiple pregnancy and assisted reproductive technologies. Int J Gynecol Obstet 64:11-25, 1999.
20. Petty MD, Leskovsek N: Legal aspects of generic substitution for NTI drugs. Responsibilities, rights, and regulations. Hosp Pract December 1999.
21. Bradley CP, Riaz A, Tobias RS, et al: Patient attitudes to over-the-counter drugs and possible professional responses to self-medication. Fam Pract 15:44-50, 1998.
22. Ernst ME, Kelly MW, Hoehns JD, et al: Prescription medication costs: A study of physician familiarity. Arch Fam Med 9:1002-1007, 2000.
23. Banahan BF, Kolassa EM: A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med 157:2080-2088, 1997.
24. Hollenbeak CS: The effect of generic competition on prescription to over-the-counter switching. Pharmaco-economics 16:661-668, 1999.
25. Keith LG, Method MW: Generic drugs in reproductive medicine: Is the value anticipated the value obtained? Int J Fertil 32:268-278, 1987.
26. Keith L: Illinois: A model for the large scale delivery of family planning services. Vital Signs. North-western Memorial Hospital, Chicago, IL p 19-21, 1977.
27. Potter LS: How effective are contraceptives? The determination and measurement of pregnancy rates. Obstet Gynecol 88:13S-23S, 1996.
28. Vasquez EM, Min DI: Transplant pharmacists' opinions on generic product selection of critical-dose drugs. Am J Health-Syst Pharm 56:615-621, 1999.